Table 1.
NOET | LIET | HIET | |||||
---|---|---|---|---|---|---|---|
Pretraining | Posttraining | Pretraining | Posttraining | Pretraining | Posttraining | ANCOVA, p-value (Treatment, Time, Interaction) |
|
Waist Circumference, cm | 98.2 ± 10.0 | 97.5 ± 8.0 | 103.8 ± 10.6 | 102.6 ± 10.4 | 103.7 ± 16.8 | 98.1 ± 13.3*¥Ψ | (0.036, 0.020, 0.055) |
Fasting Blood Glucose, mg.dL-1 | 107.7 + 14.6 | 110.4 + 16.6 | 106.7 + 13.5 | 104.0 + 10.8 | 110.2 + 20.6 | 113.8 + 26.0 | (0.675, 0.066, 0.658) |
HDL-C, mg.dL-1 | 42.7 ± 6.7 | 45.7 ± 9.1 | 44.6 ± 6.6 | 49.0 ± 10.4 | 50.9 ± 10.7 | 52.1 ± 9.1 | (0.181, 0.085, 0.233) |
Triglycerides, mg.dL-1 | 187.3 ± 77.0 | 191.5 ± 97.3 | 241.9 ± 202.4 | 213.8 ± 135.8 | 152.1 ± 43.9 | 126.7 ± 40.0 | (0.245, 0.175, 0.552) |
Systolic Blood Pressure, mm Hg | 129 ± 12 | 130 ± 11 | 135 ± 17 | 124 ± 10*,¥ | 124 ± 16 | 123 ± 15 | (0.207, 0.087, 0.046) |
Diastolic Blood Pressure, mm Hg | 75 ± 7 | 76 ± 7 | 82 ± 12 | 78 ± 10 | 76 ± 8 | 74 ± 8 | (0.706, 0.469, 0.549) |
Two-way, mixed-effects analysis of variance of covariance with repeated measures (ANCOVA) was employed to examine mean differences in pre-to posttraining values, with the baseline values serving as the covariate (see methods for details). For all analyses, linear contrasts of the means were constructed to test our a priori hypotheses. Fisher’s Restricted Least Significant Differences criterion was utilized to maintain the a priori type I error rate of 0.05.
Significantly different from baseline (p <0.05)
Significant treatment effect (post — pre) compared with NOET (p <0.05)
Significant treatment effect (post — pre) compared with LIET (p <0.05)